Teladoc Health, Inc. (TDOC)
Teladoc Health, Inc. (TDOC) from its SEC filings: 2025 revenue $2.5 billion (-2% vs the year before), net margin -8%, free cash flow $285.5 million. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Services-Offices & Clinics Of Doctors Of Medicine |
| Revenue (2025) | $2.5 billion |
| Revenue growth | -2% |
| Net income | -$200.3 million |
| Net margin | -7.9% |
| Free cash flow | $285.5 million |
| Diluted EPS | $-1.14 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | -4% |
| Cash | $774.3 million |
| Long-term debt | $42.4 million |
| Share count, 1 year | +3% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.